GLAND (GLAND) News
Follow GLAND (GLAND) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 14 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Gland Pharma Rises 4% on Nomura Buy Retain
Gland Pharma shares climbed 4% after Nomura maintained its 'Buy' rating on the stock. Separately, Kanohar Electricals surged 16% following a 140% year-on-year increase in its first-quarter profit to Rs 27.3 crore.
EQUITY | Oct 07, 2026, 07:51 AM UTC
L
Trade Spotlight: How should you trade Azad Engineering, Lloyds Metals and Energy, Gland Pharma, Indian Hotels, and others on September 30?
Equity benchmarks staged a strong recovery from the day’s low but ended about a third of a percent lower on September 29 amid weak market breadth. About 1,870 shares declined, compared with 1,380 advancing shares on the
EQUITY | Sep 30, 2026, 02:58 AM UTC
L
Top 5 Sumeet Bagadia's breakout stocks: Gland Pharma, Astra Micro, Meesho, Westlife, Ujjivan | Target price, stop-loss
New Delhi, Sept. 29 -- Sumeet Bagadia's breakout stock recommendations: The key benchmark indices of the Indian stock market extended their slide on Tuesday, with the Nifty 50 and Sensex falling further to fresh six-mont
EQUITY | Sep 29, 2026, 06:04 PM UTC
L
Gland Pharma to acquire 100% stake in Gland Pharma USA
The Board of Directors of Gland Pharma has approved the acquisition of 100 per cent of the equity share capital of Gland Pharma USA Inc. a wholly-owned step-down subsidiary of the Company, from Gland Pharma International
MNA | Sep 15, 2026, 10:37 AM UTC
L
PE majors eye Orbicular Pharma stake, valuation seen up to $1.5 bn
Mumbai, Sept. 15 -- Orbicular Pharmaceutical Technologies has attracted early interest from private equity firms including Warburg Pincus and CVC Capital Partners, as the specialty pharmaceutical firm explores a stake sa
NEWS | Sep 15, 2026, 03:03 AM UTC
L
Stocks to watch, Sept 15: HDFC Bank, BSE, broking firms, HCL Tech, Deccan Gold Mines, CESC, Glenmark, BHEL, Patel Airtemp, Lenskart, Heidelberg, AU Small Fiance Bank, Gland Pharma
Stocks to watch, Sept 15: HDFC Bank, BSE, broking firms, HCL Tech, Deccan Gold Mines, CESC, Glenmark, BHEL, Patel Airtemp, Lenskart, Heidelberg, AU Small Fiance Bank, Gland Pharma
COMMODITIES | Sep 15, 2026, 01:42 AM UTC
M
Fosun trims stake in Gland Pharma below half
Chinese pharmaceutical major Fosun Pharma trimmed its stake in Hyderabad-based injectable drugmaker Gland Pharma, reducing its holding below half. The sale was carried out by Fosun’s Singapore unit, according to the repo
EQUITY | Sep 10, 2026, 09:41 AM UTC
L
Fosun Pharma unit sells Gland Pharma shares for $294 million
Shanghai Fosun Pharmaceutical Group Co Ltd’s unit sold Gland Pharma shares for $294 million, according to TradingView News.
EQUITY | Sep 06, 2026, 08:57 AM UTC
L
Fosun Pharma sells 4.5% stake in Gland Pharma via block deal
Promoter Fosun Pharma sold equity shares worth more than Rs 2,121 crore in Hyderabad-based Gland Pharma on September 4 through open-market transactions, with the sale representing a 4.5% stake, per NSE block-deal data.
EQUITY | Sep 04, 2026, 05:26 PM UTC
M
Gland Pharma block deal trades 4.5% stake worth about Rs 2,121 crore
A block deal on Friday traded a 4.5% stake in Gland Pharma Ltd worth around Rs 2,121 crore. The sale follows reports that promoter Fosun Pharma was looking to pare its holding.
EQUITY | Sep 04, 2026, 03:56 AM UTC
L
Indian shares seen opening higher as Fed hike bets trimmed
Indian shares were on track to open higher Friday after four sessions of losses. Fading expectations for a U.S. Federal Reserve rate hike later this month lifted global equities, easing pressure on bond yields.
CENTRAL_BANK | Sep 04, 2026, 02:22 AM UTC
L
Fosun to sell 5% stake in Gland Pharma via block at ₹2,763
A ₹2,279.50 crore block deal for Gland Pharma has been launched in Hyderabad, with Fosun Pharma selling a 5% stake at ₹2,763 per share, sources said.
EQUITY | Sep 03, 2026, 01:37 PM UTC
L
These are the three Pharma stocks that should be on your radar today
Three pharma stocks — Caplin Point Laboratories, Gland Pharma and Nephrocare Health Services — are in focus on Wednesday, September 2.While Caplin Point Laboratories and Gland Pharma, post-market hours on Tuesday, inform
EQUITY | Sep 02, 2026, 02:17 AM UTC
L
Gland Pharma says USFDA concluded inspection at Visakhapatnam facilities
Gland Pharma Ltd says the USFDA concluded its inspection at the company’s Visakhapatnam facilities.
EQUITY | Sep 01, 2026, 11:44 AM UTC